Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)
NCT01762124 is an interventional trial sponsored by Medtronic Heart Valves. As of 21 Nov 2026, it is completed. It studies Congenital Heart Disease and Tetralogy of Fallot. The registry lists an enrollment of 20 participants at 3 sites in 2 countries. The registry lists a start date of 31 Oct 2012 and a primary completion date of 31 May 2015. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01762124 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Medtronic Heart Valves |
| Enrollment | 20 |
| Registered sites | 3 |
| Countries | 2 |
| Conditions | Congenital Heart Disease and Tetralogy of Fallot |
| Start | 31 Oct 2012 |
| Primary completion | 31 May 2015 |
| Study completion | 31 Jul 2020 |
| Last update posted | 7 Aug 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Lee Benson, MD
The Hospital for Sick Children, Toronto, Canada
Principal Investigator - Lisa Bergersen, MD, MPH
Boston Children's Hospital, Boston, Massachusetts, USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Boston Children's Hospital
Boston
- Nationwide Children's Hospital
Columbus
- the Hospital for Sick Children
Toronto, Ontario
United States, by state
Outside the United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01762124
Each answer restates registry values shown on this page.
What is NCT01762124?
NCT01762124 is an interventional trial sponsored by Medtronic Heart Valves. It studies Congenital Heart Disease and Tetralogy of Fallot.
Who leads NCT01762124?
The registry names John P. Cheatham, MD (principal investigator, Nationwide Children's Hospital), Lee Benson, MD (principal investigator, The Hospital for Sick Children, Toronto, Canada) and Lisa Bergersen, MD, MPH (principal investigator, Boston Children's Hospital, Boston, Massachusetts, USA) as overall officials.
Where does NCT01762124 run?
The registry lists 3 sites in 2 countries. Most sites are in these countries: United States (2) and Canada (1).
When did NCT01762124 end?
The registry lists a primary completion date of 31 May 2015 and a study completion date of 31 Jul 2020. The sponsor last updated the record on 7 Aug 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.